Interferon beta remains a cornerstone disease-modifying therapy in relapsing forms of multiple sclerosis. However, its utility is compromised by immunogenicity, whereby patients develop anti-drug ...
Why does the COVID-19 virus make some people sicker than others? For years, scientists have looked to a critical piece of immune system machinery - known as the interferon pathway - for answers. There ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results